(2)
Investment will accelerate company s global expansion and consolidate its industry-leading position in healthtech solutions
BANGALORE, India and PRINCETON, N.J., Feb. 03, 2021 (GLOBE NEWSWIRE) The Carlyle Group (NASDAQ: CG), Brighton Park Capital and Indegene, the Bangalore-headquartered enterprise healthtech solutions provider, today announced that Carlyle and Brighton Park Capital will acquire minority stakes in the company for US$200 million. The transaction, which is subject to customary regulatory approvals, consists of a secondary sale from existing shareholders of Indegene and a primary investment into the company.
Founded in 1998 by five first-generation entrepreneurs, Indegene has emerged as the leading digital transformation partner to the global life sciences industry. With more than 3,000 employees across North America, Europe, China, Japan and India, Indegene provides technology platforms and commercialization services to pharmaceutical, biotechnology, and med
Carlyle and Brighton Park agree to invest US$200 million in Indegene
Carlyle and Brighton Park agree to invest US$200 million in Indegene
Investment will accelerate company’s global expansion and consolidate its industry-leading position in healthtech solutions
BANGALORE, India and PRINCETON, N.J., Feb. 03, 2021 (GLOBE NEWSWIRE) The Carlyle Group (NASDAQ: CG), Brighton Park Capital and Indegene, the Bangalore-headquartered enterprise healthtech solutions provider, today announced that Carlyle and Brighton Park Capital will acquire minority stakes in the company for US$200 million. The transaction, which is subject to customary regulatory approvals, consists of a secondary sale from existing shareholders of Indegene and a primary investment into the company.